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Most of the available data on chemical interactions have been obtained in animal studies
conducted by administering high doses of chemicals by routes and scenarios different from
anticipated human exposures. A mechanistic approach potentially useful for conducting dose,
scenario, species, and route extrapolations of toxic interactions is physiological modeling. This
approach involves the development of mathematical descriptions of the interrelationships among
the critical determinants of toxicokinetics and toxicodynamics. The mechanistic basis of the
physiological modeling approach not only enables the species, dose, route, and scenario
extrapolations of the occurrence of toxicokinetic interactions but also allows the extrapolation of
the occurrence of interactions from binary to multichemical mixtures. Examples are presented to
show the feasibility of predicting changes in toxicokinetics of the components of complex
chemical mixtures based on the incorporation of binary interaction data within physiologically
based models. Interactions-based mixture risk assessment can be performed by simulating the
change in the tissue dose of the toxic moiety of each mixture component during combined
exposures and calculating the risk associated with each tissue dose estimate using a tissue
dose versus response curve for all components. The use of such a mechanistic approach
should facilitate the evaluation of the magnitude and relevance of chemical interactions in
assessing the risks of low-level human exposures to complex chemical mixtures. Environ
Health Perspect 106(Suppl 6):1377-1384 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/
1377-1384haddad/abstract.html
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Mechanistic risk assessment approaches for
single chemicals are fairlywell developed but
for chemical mixtures they are only in the
developmental stage. The default approach
in mixture risk assessment assumes additiv-
ity in terms of the dose or the response.
Whereas the response additivity is applied
for carcinogens, the dose additivity is
applied in the case of systemic toxicants
acting by similar mechanisms (1,2). The
additivity assumption is valid only when
there is no interaction among the compo-
nents ofthe mixture at the exposure, toxi-
cokinetic, and toxicodynamic levels at
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relevant exposure concentrations in both
the test animal species and humans.
Several environmental chemicals
interact with each other by various mech-
anisms that are dependent on the dose,
dosing regimen (i.e., single or repeated
exposure), exposure pattern (i.e., pretreat-
ment, coadministration, or postadmin-
istration), and/or exposure route of one
or both chemicals (3). Most of the inter-
action studies reported to date have been
conducted in laboratory animals by
administering high doses of one or both
chemicals by routes and scenarios often
different from anticipated human expo-
sures (4). Further, information on the
toxicological consequences oflow-level or
chronic exposures to binary chemical
mixtures, which show significant inter-
actions when administered acutely, is
often unavailable (3).
Typically, in the health risk assessment
process for chemical mixtures, the avail-
able data on toxic interactions among
components are not taken into account.
The present situation ofneglecting data on
binary chemical interactions (e.g., synergism,
antagonism) will not change unless and
until a tool or methodology can be devel-
oped for extrapolating the results ofanimal
studies on binary chemical interactions to
humans (i.e., by accounting for the route,
scenario, exposure concentration, and
species differences), and predicting the
potential modulation of binary chemical
interactions by other chemicals present
within complex mixtures.
These concerns can be addressed with
the use ofa physiologically based modeling
approach. Physiologically based modeling
refers to the process of reconstructing
mathematically the anatomic-physiological
characteristics of the organism of interest
and describing the complex interplay
among the critical determinants of toxi-
cokinetics and toxicodynamics. The bio-
logical and mechanistic basis of the
physiological modeling approach allows
the conduct ofvarious extrapolations (i.e.,
high dose to low dose, route to route,
species to species, scenario to scenario, and
binary to more complex mixtures) of the
occurrence of toxicokinetic interactions
among components ofchemical mixtures.
This article provides an overview of the
conceptual basis of physiological models
used for simulating toxicokinetic interac-
tions in chemical mixtures and discusses its
implications for developing mechanistic
mixture risk assessment strategies.
Physiological Modeling of
Toxicokinetic Interactions:
Conceptual Basis
The feasibility of using physiologically
based toxicokinetic (PBTK) models to
describe, predict, and extrapolate the
extent and magnitude of the occurrence of
interactions for various dose levels, scen-
arios, species, routes, and mixture com-
plexities arises from the very nature and
basis of these models. PBTK models of
mixtures correspond to a set of individual
chemical models interconnected via the
mechanism of interaction. In PBTK mod-
els for individual chemicals, the organism
is frequently represented as a network of
tissue compartments (e.g., liver, fat, slowly
perfused tissues, and richly perfused tissues)
interconnected by systemic circulation.
Absorption of chemicals in the environ-
mental medium may be via pulmonary,
dermal, or oral routes. The amount
absorbed per unit time can be calculated
within the model; alternatively, the change
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in chemical concentration in blood or the
tissue representing the portal of entry may
be simulated using appropriate equations
(Table 1). The chemical in the arterial sup-
ply binds to blood components and/or
enters the various tissue compartments
where it may be dissolved in lipid and water
components and be bound to tissue macro-
molecules. The rate of change in the
amount ofchemical in each tissue compart-
ment is described with mass balance differ-
ential equations (MBDEs). In the case of
metabolizing tissues these MBDEs accom-
modate appropriate mathematical des-
criptions (e.g., saturable or first-order
processes). Finally, the concentration of
chemical excreted in biological fluids
(exhaled air, urine) may be calculated using
algebraic or differential equations (5). The
equations listed in Table 1 contain several
parameters, i.e., critical determinants of
chemical uptake and disposition. These
determinants can be classified into four cat-
egories, namely, physiological, biological,
physicochemical, and biochemical (Table
2). If the numerical values of any ofthese
determinants of chemical uptake and dis-
position are altered during coexposure to
other chemicals, then a toxicokinetic inter-
action is likely to result. Physiological
models oftoxicokinetic interactions should
then account for such alterations at the
mechanistic level to provide simulations of
blood or tissue concentration profiles of
chemicals in mixtures.
To construct a PBTK model for a
binary mixture, one must initially construct
two single-chemical models. The two mod-
els are then linked mechanistically at the
level of a tissue or blood compartment.
This is accomplished by modifying the
numerical value(s) for mechanistic deter-
minant(s) in mathematical expressions of
absorption, distribution, metabolism, or
excretion. Toxicokinetic interactions can
then be viewed as a consequence of one
chemical modifying the mechanistic deter-
minant of the toxicokinetics of another
chemical in the mixture.
The absorption profile of one chemical
may be altered in the presence of another
chemical as a result of interference with
an active uptake process or, perhaps, of
modulation ofthe critical biological deter-
minants of uptake (e.g., Qp, Q,). For
example, hydrogen cyanide at low expo-
sure concentrations causes an increase in
Qp, thus potentially increasing the pul-
monary uptake of other chemicals (6).
To describe such absorption-level inter-
actions in a PBTK model, chemical-
specific quantitative information on the
Table 1. Mathematical descriptions of some pharmacokinetic processes used in physiologically based toxicokinetic
models forvolatile organiccompounds.a
Pharmacokinetic processes
Uptake
Pulmonary
Dermal
Oral
Distribution
Protein binding
Tissue distribution
Clearance
First-order
Saturable process
Equations
-QpCi +QICv
a Q+ (Qp /P,)
= KpS(Cair - (Csk/P:a)) + Q sk(Ca (Csk/P,b))
dt
dA° = K D e-Rt
dt
0 0
C_n,BKbCf, Cbd
(1 + KbCfr)
dt =Qt(Ca.Cvt)
dAmet =Q1. E. Ca
dt
dt Km+Cvt
dose dependency ofthese effects (e.g., Q
QC vs exposure concentration) is requirecC
The distribution profile of a chemical
can be altered by another chemical if it
affects certain critical physicochemical,
physiological, or biochemical parameters.
Some chemicals may alter the solubility
characteristics of another chemical. For
example, cyanide forms complexes with
essential metals, resulting in a change in
their tissue concentrations and distribution
pattern due to changes in solubility and sta-
bility (7-12). Several dithiocarbamates
increase the uptake of lead through the
blood-brain barrier by forming lipophilic
complexes (13). The distribution phase
interactions resulting from changes in physi-
ological parameters such as liver volume (V1)
or hepatic blood flow rate (Q1) are invoked
by phenobarbital and ethanol. Chemicals in
mixture or their metabolites may compete
for binding to various macromolecules such
as hemoglobin, albumin, metallothionein,
or tissue receptors. Competition for plasma
protein binding has been modeled by
accounting for the number ofbinding sites,
total protein level, dissociation constants,
and the concentration ofthe unbound form
ofboth the substrate and the inhibitor (14).
Some chemicals can also increase the num-
ber ofbinding sites through an induction
process [e.g., induction ofmicrosomal bind-
ing proteins and cytosolic proteins by
2,3,7,8-tetrachlorodibenzo-p-dioxin (15)].
Metabolic interactions may occur
because of one chemical inducing or
inhibiting the metabolism of another
chemical in the mixture. Metabolic inhibi-
tion occurs when a chemical competes
directly with another chemical for an enzy-
matic binding site (competitive inhibition),
Table 2. Partial list of mechanistic determinants that
may be modified during toxicokinetic interactions.
Parameters Mechanistic determinants
Physiological Cardiac output(Qc)
Breathing rate(Qp)
Tissue blood flow rate(Qt)
Glomerularfiltration rate(GFR)
Biological Tissue and blood volumes (Vt, Vb)
Concentration ofmetabolizing
enzymes(Et)
Concentrations of binding proteins (1)
Number of binding sites (n)
Physico- Blood:air partition coefficient(Pb)
chemical Tissue:blood partition coefficient(Pt)
Oral absorption rate constant(KQ)
Dermal permeability coefficient(Kp)
Biochemical Maximal velocityfor metabolism (Vmax)
Binding association constant(Kb)
Michaelis affinity constant(Kn)
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aAdapted from Krishnan and Andersen (5). Abbreviations: A, amount; C, concentration; D, dose; E, hepatic extrac-
tion ratio; K0, rate of oral absorption; P, partition coefficient; PA, permeation across tissue membrane; 0, blood
flow rate; S, skin surface; V, volume. Subscript abbreviations: a, arterial blood; bd, bound; fr, free; i, inhaled; I,
liver; met, metabolized; o, oral; s:a, skin:air; s:b, skin:blood; sk, skin; t, tissue; v, venous blood; vt, venous blood
leaving tissue. All other symbols are defined in Table 2.
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when a chemical binds directly to the
enzyme-substrate complex but not to the
free enzyme (uncompetitive), or when it
does both of these (noncompetitive). The
inhibitory effect of one chemical on
another is modeled by including a term
that describes the quantitative manner in
which Km and V,,,. are modified (Table 3).
Once the mechanism of interaction is
hypothesized or determined and the two
individual chemical PBTK models are inter-
connected, the integrated binary chemical
mixture model is ready to be used for pre-
dicting the consequences of toxicokinetic
interactions at various dose levels, exposure
routes, species, and scenarios. This kind of
modeling exercise can help determine the
relative importance ofan interaction for risk
assessment purposes. Of the several inter-
action PBTK models published so far
[reviewed by Simmons (16)], most ofthem
have only been used to evaluate the mecha-
nistic basis of toxicokinetic interactions.
Only a few studies have demonstrated the
use ofPBTK models for conducting extrap-
olations ofthe occurrence and magnitude of
toxicokinetic interactions (17-23).
High-Dose to Low-Dose
Extrapolations
High-dose to low-dose extrapolations of
toxicokinetic interactions can be accom-
plished by PBTK modeling because the
mathematical descriptions used in PBTK
models account for the nonlinear kinetic
behavior of individual chemicals and the
mixture effects. The toxicokinetic non-
linearity is often related to a change in the
numerical values of biochemical, physio-
logical or physicochemical determinants
that is not strictly proportional to the
change in dose or exposure concentration.
The ability to conduct high-dose to low-
dose extrapolation oftoxicokinetic interact-
ions using PBTK models may be examined
with metabolic induction/inhibition as the
Table 3. Mathematical representation of the modifica-
tions of maximal velocity for metabolism (Vmax) and
Michaelis affinity constant (Kin) during metabolic
inhibition.a
Mechanism Modification Modification
of inhibition of Km of Vmax
Competitive ax Km None
Uncompetitive Km/a Vmax/a
Noncompetitive None Vmaxla
a= r + Kj' where CVII represents the liver
i venous concentration of inhibitor
and K, represents the inhibition
constant.
mechanism. In such cases, the binary
toxicokinetic interaction model accounts
for the nonlinearity arising from two phe-
nomena: the saturable nature of the met-
abolism of individual chemicals and the
relative importance of the metabolic inter-
action mechanism as a function of sub-
strate concentration. The saturation of
metabolism at a high exposure concentra-
tion ofa chemical leads to a situation that
is characterized by the absence of sig-
nificant inhibitory interaction effects on
the hepatic extraction ratio at such con-
centrations; however, the interactive effect
becomes more evident at subsaturation con-
centrations. In the case of enzyme in-
duction, the effect is more pronounced at
high exposure concentrations (i.e., at which
metabolism is capacity limited) than at low
exposure concentrations (i.e., at which
metabolism is perfusion limited). The rel-
ative importance and thus the influence of
metabolic interactions will depend on the
substrate concentration, particularly the
range in which saturation occurs. The sat-
urable nature of the metabolism of the
inhibitor chemical will also lead to non-
linearity in terms ofits effects at a constant
exposure concentration of a substrate.
Because the saturable nature of the met-
abolism of mixture components and the
magnitude and mechanism of the inter-
active effects are incorporated within the
PBTK models, these models are useful for
conducting high-dose to low-dose extrapo-
lations of the consequence of toxicokinetic
interactions. This particular application of
PBTK models has been explored in the
context ofdetermining the relative impor-
tance of interaction data for health risk
assessments and for establishing interaction
thresholds (19-23).
Route-to-Route Extrapolations
The tissue or blood concentration versus
time-course profiles of chemicals may be
different depending on the route of expo-
sure (e.g., intravenous, oral, inhalation,
dermal). Therefore, the time course of the
effective concentration ofa chemical at the
interaction site may differ according to
route ofexposure, thus leading to a route-
dependent magnitude and profile of the
interaction effect. The route-to-route diff-
erence in bioavailability and toxicokinetics
can be accounted for by using appropriate
mathematical descriptions of absorption
(Table 1). Route-to-route extrapolations of
toxicokinetics using PBTK models have
been successfully performed for several
individual chemicals. The approach
involves shutting off one pathway and
introducing the chemical via another route
(5). Because equations for absorption via
each of the multiple routes are included in
the PBTK model for each of the mixture
components, all one does is specify chemical
concentration in the respective exposure
media. In the case of a mixture PBTK
model, the same or different routes for the
components can be chosen. For example,
both chemicals may be administered orally
or one by oral ingestion and another by
inhalation. Such an approach has been used
by Pelekis and Krishnan (23) to conduct
route-to-route extrapolation of the occur-
rence of metabolic interactions between
toluene (TOL) and dichloromethane
(DCM). The PBTK modeling method-
ology, in effect, should permit the sim-
ulation of the extent and consequence of
toxicokinetic interactions following com-
bined multiroute exposures to chemicals.
Interspecies Extrapolations
The usefulness of PBTK models in the
conduct of interspecies extrapolations of
single chemicals is well documented
(5,24). However, there have been only
limited efforts so far to demonstrate the
usefulness ofrodent PBTK models in pre-
dicting the toxicokinetics of chemical
mixture in humans. The procedure
involves substituting the numerical values
of physiological, physicochemical, and
biochemical parameters, including the
interaction parameters, with those for the
species of interest. This must be done for
each component model of the mixture
PBTK model. The rat-to-human extrap-
olation of toxicokinetic interactions
using the PBTK modeling approach has
been validated for a binary mixture
(TOL/m-xylene [XYL]) and a ternary
mixture (TOL/XYL/ethylbenzene [EBZ])
(20,25). In these studies, the values ofthe
interaction parameter (i.e., Ki for compet-
itive inhibition mechanism) determined
in animal studies were kept unchanged in
the human PBTK models. Treating the
metabolic inhibition constants as species
invariant implies that the nature and mag-
nitude of the competition between the
alkyl benzenes for binding to cytochrome
P4502E1 for metabolism does not change
between species. This assumption can be
accepted as the default because the sub-
strates (TOL, XYL, EBZ) and the iso-
enzyme form (2E1) involved are the same
despite the fact that the species being con-
sidered are different (rat vs human).
Although the inhibition potency of a
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chemical is assumed to be the same
regardless ofthe species, it is obvious that
the hepatic venous concentration of the
chemicals might vary from one species to
another, thus accounting for species diff-
erences in the overall inhibition effects, if
any. Such an approach has recently been
used by Pelekis and Krishnan (23) to eval-
uate the relevance for humans ofa toxico-
kinetic interaction between TOL and
DCM characterized in rats. Application of
PBTK models along these lines would
facilitate a priori characterization of the
threshold of interactions in humans and
identification of those interactions that
may be ofconcern to humans exposed to
low concentrations.
Scenario-to-Scenario Extpolations
Scenario extrapolations to assess the
potentially varying nature and magnitude
of toxicokinetic interactions are essential
because changing the exposure scenarios
may invoke different mechanisms or alter
the kinetic profiles of chemicals. If the
change in exposure duration is the sole
factor ofconcernall one must do is adjust
the length of exposure (TCHNG) in the
PBTK model. Accordingly, the length of
time during which a particular tissue con-
centration is maintained might vary
according to the scenario ofexposure. This
may have direct influence on the extent of
interactive effects seen, as the effective
concentration ofthe inhibitor is an impor-
tant determinant of the outcome of inter-
actions. The application of PBTK models
for simulating the kinetics of various
chemicals as a function ofexposure scen-
arios is well documented (26-28). The
same approach can be used to describe the
change in exposure scenarios in the in-
dividual chemical models of a mixture
PBTK model. In some cases mathematical
descriptions to account for time-depen-
dent processes such as induction of a
metabolizing or binding protein may have
to be additionally incorporated (15,29).
The applicability of PBTK models for
simulating the kinetics of chemical mix-
tures in humans following changes in
exposure duration and concentration has
been demonstrated by Tardifet al. (20).
The inclusion of the information on
toxic interactions between two chemicals
within the regular risk assessment process
(even ifthey are for a relevant exposure sce-
nario, species, route, and dose level) has
been hampered by the fact that such data do
not represent the complete picture (30).
Chemicals do not just coexist in two but in
multiple numbers, and as such the toxicity
of two interacting chemicals might further
be altered by the other components ofthe
mixture. The toxicity ofcomplex mixtures
is determined by the outcome of interac-
tions not only at the binary level but also at
other, higher levels (e.g., ternary, quater-
nary). There has been a lack ofuseful tools
essential for predicting higher order interac-
tions within complex mixtures. The poten-
tially useful tools in this context are
statistical, empirical, and mechanistic mod-
els. Statistical and empirical models are con-
structed on the basis ofavailable data and
therefore cannot be used for extrapolations.
On the other hand, the mechanistic PBTK
models are constructed on the basis ofthe
quantitative interrelationships among the
critical determinants of the process of
interest and therefore are potentially useful
in this context.
Extrpolation from Binary
to HigherOrderLevels
One of the approaches for modeling
toxicokinetic interactions in mixtures
involves identifying and linking all indi-
vidual chemical models via interaction
terms. PBTK models for mixtures of any
level of complexity can then be created as
long as the quantitative information on
the mechanism for each interacting chem-
ical pair is available or can be hypo-
thesized. According to this methodology,
for modeling the kinetics of the com-
ponents of complex mixtures, plausible
binary interactions need only be char-
acterized. In a mixture ofthree chemicals,
for example, there are three two-way
interactions (Figure 1). The first step is to
write the models for each component of
the mixture. Then the single-chemical
models should be interconnected at the
binary level by modifying the appropriate
equations. If we consider competitive
metabolic inhibition as the mechanism of
interaction, the equation for calculating
the rate of the amount metabolized
(RAM) of each component should be
modified appropriately (Table 4).
Logically, this PBTK modeling approach
should be applicable to predict higher
order interactions in mixtures ofany com-
plexity, invoking various kinds of mecha-
nisms of interactions among components.
It is important to note that all linkages
involving mixture components are of
binary nature only (Table 4).
If the model considers interactions at
the binary level alone, how is it possible to
simulate the consequence of a higher
order interaction (e.g., involving three
chemicals)? This is where the unique use-
fulness of PBTK modeling becomes evi-
dent. Let's assume that the binary
chemical interaction between A and B has
been modeled. Following the addition of
another chemical, C, the PBTK model
not only simulates the binary interactions
involving C(i.e., C-A, C-B) but also the
modulatory effect of C on the interaction
between A and B. Once we describe the
inhibitory effect of C on B, this would
result in a reduction in the rate of B
metabolized and consequently an increase
in its concentration in venous blood leav-
ing the liver (CQ,B). CVIB is the numerator
of the term representing the inhibitory
effect ofB on A (i.e., 1 + CIB1KiBA) (Table
4). Because the exposure to chemical C
increases CVIB, this translates into a modi-
fication of the magnitude of the inter-
active effect of B on A. Similarly, C may
also affect the concentration ofA, which
would then result in a change in the mag-
nitude of the interactive effect ofA on B.
The PBTK model framework can also
simulate similar phenomena affecting the
concentration of Cbecause all components
of the mixture are linked. Based on this
analogy it will be possible to predict the
influence ofthe addition ofanother chem-
ical, D, to the ternary mixture, and so
forth (Table 4). When D is added to an
existing ternary mixture PBTK model for
chemicals A, B, and C, we need to con-
sider only three additional binary inter-
actions (Figure 2, small dashed lines). By
doing this, the modulating effect of D on
the C-A and B-A interactions will be auto-
matically simulated because all components
are linked with each other within the
PBTK framework. The effect of D on the
kinetics ofA will in turn affect the kinetics
A
KiAB, KiBA KiAC, KjCA
B C
K,BC, KjCB
Figure 1. Interactions among the components of a
ternary mixture. Kixyrefers to the interactive effect of
chemical Xon chemical Y.
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Table 4. Mathematical description of the rate of amount metabolized of a chemical present alone or with one or
more chemicals that compete forthe same but saturable enzyme catalytic sites.a
Chemicals in mixture, no. Chemical RAM equation
A
A
B
A
B
C
A
B
C
D
VmaxA CvIA
KmA +CV1A
Vm,A CVIA
KJ 1+ CvIB +C
KiBA
VmaIxB v CvIB
KmB 1 + CVUA +CvB
iAB
VmaXA CV/A
KmA( +Cv/B + cvIC )+CVL4 KiBA KiCA
VmaxB vCvB
KmB(1+ + C CvIB
KiAB KiCB
VmaxC CVIC
Kmc(+ Cv/ + CvIB ) +CvlC KiAC iBC
Vmao A CV/A
Km 1 + CvIB + + CvID +C
KiBA KiCA KiDA
Vmax B *Cv/B
KmB 1 + v/A+ + I +CvIB
KiAB KiCB KiDB
VmvxC v/C
KmC 1+ Cv/A + Cv/ + Cv/D )+Cvlc
iAC iBC iDC
VaxD CvID
KmD 1 + Cv- + + I +CvID
KiAD KiBD KiCD
'KXy, inhibition constant, for the effect of chemical Xon chemical Y C,1X, concentration of chemical Xin venous
blood leaving liver.
ofB, C, and D. Any modulation of a binary
interaction will affect the kinetics of other
chemicals that are part of the network of
binary interactions present in the mixture.
The same considerations are applicable
when another chemical, E, is added to the
quaternary mixture. After adding the four
new binary interactions (E-A, E-B, E-C,
and E-D), chemical Ewill become an inte-
gral part ofthe network ofthe components
of the mixture and any modulation of a
binary interaction involving Ewill have
repercussions on all the others (Figure 2).
The novel thing about this approach is that
it only requires data on binary interaction
mechanisms for predicting the magnitude
and consequence of higher order inter-
actions within complex mixtures.
Tardifet al. (25) validated this approach
for predicting the kinetics ofcomponents of
a ternary mixture ofalkyl benzenes. These
authors hypothesized, based on the possibil-
ity that alkyl benzenes are substrates of
cytochrome P4502E1, that they are likely to
compete for the enzyme catalytic site.
Initially, individual chemical PBTK models
A+-----I,- ---
B+ ' ~~~~C
N'\
E
/- f
/
Figure2. Interactions among the components ofa five-
chemical mixture.
were constructed in the rat. All individual
chemical models were then interconnected
by inserting a binary interaction term for
metabolic inhibition (i.e., alternate descrip-
tions ofcompetitive, uncompetitive, and
noncompetitive inhibitions) in the RAM
equations. Once all individual chemical
PBTK models were linked by binary inter-
action terms, the metabolic inhibition con-
stants for each pair ofmixture components
were obtained by fitting model simulations
to experimentally measured venous blood
concentrations in rats exposed to mixtures.
The Kivalues were determined for all three
types ofinhibition, and competitive inhibi-
tion appeared to be the most plausible
mechanism ofmetabolic interaction (25).
With the inclusion of the Ki values for
all binary interactions, the mixture PBTK
model was used to simulate the kinetics of
each component in rats following a 4-hr
inhalation exposure to a mixture of 100
ppm each ofTOL, XYL, and EBZ. For all
three chemicals, the venous blood con-
centration kinetics simulated by the binary
interactions-based mixture PBTK model
compared well with experimental data
(25). This approach has also been used to
predict the carboxyhemoglobinemia result-
ing from DCM exposure in the presence of
aromatic hydrocarbon solvents, i.e., TOL,
XYL, and EBZ (19). Based on the results
of this simulation study, Krishnan and
Pelekis (19) reported that the threshold for
DCM-TOL interaction diminished with
increasing number ofinhibitor chemicals.
This observation can be explained with the
change in Cvl that occurs during multi-
chemical interactions at the metabolism
site. In the study by Krishnan and Pelekis
(19), for example, connecting the PBTK
model for TOL to the existing DCM
model based on competitive inhibition
mechanism increases the liver venous blood
concentration of DCM. The addition of a
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VmaxACA + VmaXACA
KmA +CA K C(1+ GB )1C
A1~~\KmB)
Vmax CB + VmaxBGB
KmB + B K (1 CA C KmB+CB K~~~mjl K
G
Figure 3. Predictability of the effect of benzene (X) on the interacting binary pair of dichloromethane (A) and
toluene (B). These chemicals are substrates of CYP2E1 and are assumed to compete for metabolism. Vmaxrefers to
the maximal velocity for biotransformation; Km refers to the Michaelis affinity constant; Cterms are concentrations
of unchanged chemicals in the venous blood leaving liver. The equations on the left side of the thin arrows repre-
sent metabolism of A and Bwhen they are present alone and on the right-hand side the equations represent the
modification of the rate of their metabolism in the presence of an inhibitor (A or B). With the addition of Xto the
binary mixture of A-B, all one does is include the constants representing metabolic inhibition between Xand A
and Xand B in the PBTK model. In this example, the inhibition constants are set equal to the Km of the inhibitor.
Adapted from Krishnan and Pelekis (19).
third chemical, XYL, to the binary mixture
affects the magnitude ofthe existing binary
interaction of DCM-TOL by increasing
the CQi ofTOL and that of DCM (Figure
3). Similarly, the addition of EBZ to the
ternary mixture affects the kinetics of all
three solvents. The magnitude ofthe mod-
ulation of interactions invoked on the
addition ofanother chemical to an existing
network ofbinary interactions depends on
its inhibition potency and also on its CQ.
With increasing complexity ofmixtures,
the Ki for binary interactions is not modi-
fied; rather, the C>l is increased according
to the potency and number of the
inhibitors. The increasing effective con-
centration ofchemicals in a mixture is due
to a cascade of inhibitory events at the
binary level. This is why we tend to see a
more marked inhibitory effect on the
metabolism of a substrate at a specific
exposure concentration with increasing
number ofinhibitors.
Though the previous discussion and
examples published to date address com-
petitive inhibition as the sole mechanism
of interactions, this conceptual modeling
approach is applicable for situations
involving various other kinds of inter-
action mechanisms. For example, these
can be at the level of absorption (e.g.,
alteration of ventilation rate, skin per-
meability coefficient), distribution (e.g.,
competition for protein binding sites,
alteration ofthe concentrations ofbinding
proteins, alteration of blood flow), and
metabolism (e.g., enzyme induction). The
methodological approach reviewed in the
preceding paragraphs provides a systematic
framework for modeling and dealing with
interactions occurring in increasingly
complex mixtures. Every time a new
chemical is added to an existing mixture,
one must simply describe the additional
binary interactions within the PBTK
model framework. This alone would
appear to be sufficient for predicting
changes in tissue dosimetry due to the
higher order interactions occurring in
complex chemical mixtures.
Physiological Modeling of
Toxicokinetic Interactions:
Implications for Mixture Risk
Assessment
The extrapolation issues (i.e., high dose to
low dose, route to route, interspecies, sce-
nario to scenario, binary to multicomponent
mixtures) relating to the consideration of
interaction data in the risk assessment
process can be addressed with the use of
PBTK models. However, the exact nature
in which the PBTK model-based extra-
polations can be used for quantitative mix-
ture risk assessment must be clarified. The
mixture PBTK models simulate the
altered tissue dose of chemicals during
mixed exposures. Therefore, the model
simulations of change in tissue dose of
mixture components can be used along
with tissue dose-response curves available
for each of the mixture components to
assess the risk attributed to each of the
mixture components. It may be useful to
briefly review the tissue dose-based quan-
titative risk assessment approach for indi-
vidual chemicals (31). The following
steps represent the methodological aspects
involved in the conduct of a tissue
dosimetry-based assessment of cancer risk
assessment ofsingle chemicals:
1. Determining the quantitativerelationship
between target tissue dose of the toxic
moiety and exposure concentration of
the parent chemical in the test animal
(using rodent PBTKmodel);
2. Determining the relationship (e.g.,
with linearized multistage model)
between the target tissue dose obtained
in step 1 and the tissue responses seen
in animal toxicology studies (e.g.,
cancerbioassays);
3. Using the relationship in step 2 to
determine the tissue dose that corre-
sponds to a given level ofrisk, one case
of excess cancer per million individuals
exposed over lifetime; and
4. Using a human PBTKmodel to estimate
the exposure concentration of the
chemical that provides tissue dose
equivalent to that estimated in step 3.
This will then be the environmental
concentration ofthe chemical that cor-
responds to apredefined level ofaccept-
able risk (i.e., one in a million in the
presentexample).
This approach improves the con-
ventional dose-response relationship by
enabling the examination of the relation-
ship between the exposure concentration
and tissue dose and tissue dose and tissue
response. In the context ofcomplex chemi-
cal mixtures, the change in response, i.e.,
infra-additive or supra-additive toxicities,
can be viewed as a consequence ofeither a
change in the target tissue dose ofthe toxic
moiety per unit exposure concentration or
a change in the tissue response to unit tis-
sue dose during combined exposures. The
former is a consequence of toxicokinetic
interactions whereas the latter is the conse-
quence oftoxicodynamic interactions. In
this paper the examples and methodology
discussed are limited to the consideration
oftoxicokinetic interactions.
Accordingly, toxicological interactions
(i.e., increase or decrease in toxicity) result
because ofan increase or decrease in the tar-
get tissue dose per unit exposure concen-
tration of a chemical in complex mixtures.
For example, a chemical at exposure con-
centration of 10 ppm (arbitrary) producesA
units ofinternal dose in humans. The corre-
sponding risk (carcinogenic or non-
carcinogenic) can be assessed by using the
tissue dose versus response curve (Figure 4).
On the other hand, during combined expo-
sure with, for example, 10 other chemicals
at 1 ppm (arbitrary), the tissue dose ofthe
toxic moiety ofthe first chemical may no
longer be A; it might be greater than A, i.e.,
S. Consequently, the risk associated with 10
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Figure 4. A portion of the dose-response curve for an
individual chemical. With the knowledge ofthe change
in the internal dose of a chemical during mixed expo-
sures (1, A, or S), the corresponding response can be
determined from this plot.
ppm ofthe first chemical would be greater
than what is expected based on additivity
principle (Figure 4).
The modulation of the target tissue
dose ofeach individual chemical within a
complex mixture can be simulated using
the PBTK modeling approach as long as
the binary interaction mechanisms are
known or hypothesized. The tissue dose-
based risk assessment for mixtures can then
be conducted in the same way as for
individual chemicals. The following are the
steps involved in the application of PBTK
models for the conduct of risk assessment
for chemical mixtures:
1. Construct exposure concentration versus
tissue dose andtissuedose-response curves
for all relevant components ofa mixture
usingsingle-chemical PBTKmodels;
2. Obtain predictions of tissue dose of
each mixture component in humans
exposed to predefined levels using the
interactions-based PBTKmodel; and
3. Combine the results ofsteps 1 and 2 to
determine the potentially altered
response for each component during
mixed exposures.
Here, the PBTK-based dose-response
curves generated for all mixture components
are being used alongwith the simulations of
the mixture PBTK models that correspond
to the tissue dose anticipated during mixed
exposures. Ifthe tissue dose ofa component
predicted using the interactions-based
PBTK model is the same as that provided
by a single-chemical PBTK model, itwould
mean that the target tissue dose was not
altered during combined exposures.
Overall, the PBTK modeling approach to
mixture assessment requires the identifi-
cation and characterization ofthe modula-
tion of the mechanistically relevant dose
surrogate for each mixture component
during combined exposures.
For interactions that occur because of
toxicokinetic alterations, there is no need
to generate new dose-response curves for
mixtures ofvarious complexities because
the toxicological potency of components
does not change-it is only the tissue dose
that changes. In the equation for calcu-
lating risk all one does is account for the
change in target tissue dose due to kinetic
interactions (Figure 5). In cases where toxi-
codynamic interactions occur, the same
equation depicted in Figure 5 can be used;
however, it is important to note that toxi-
cological consequences during mixed
exposures do not result from change in tis-
sue dose but result from a modification of
the toxicodynamics or overall potency of
mixture components. The current research
in the areas of toxicokinetic and toxi-
codynamic modeling should facilitate the
implementation and further validation of
the interactions-based approaches for the
risk assessment ofchemical mixtures.
Components -> Interactions , Mixtures
Potency x Tissue dose Ris
Potency x Tissue dose = Risk |
Figure 5. The conceptual basis of PBTK model-based
quantitative risk assessment of chemical mixtures.
Appendix: Notation
interaction factor
concentration ofbinding proteins
amount metabolized
amount orally absorbed
amount in skin
arterial blood concentration
air concentration
unbound chemical concentration
inhaled concentration
skin concentration
tissue concentration
venous concentration
venous concentration leaving liver
concentration ofan inhibitor in venous blood
leaving liver
concentration in venous blood leaving tissue
dichloromethane
oral dose
hepatic extraction ratio
ethylbenzene
metabolizing enzyme concentration
glomerular filtration rate
association constant for protein binding
constant reflecting the inhibitory effect
ofchemical Xon Y
Km
KO
Kp
MBDE
n
Pb
PBTK
ppm
PP
Ps:a
Ps.b
Pt
QI
Qt
RAM
S
TCHNG
TOL
Vb
V,
Vmax
Vt
XYL
Michaelis-Menten affinity constant
oral absorption rate constant
dermal permeability coefficient
mass balance differential equations
number ofbinding sites per proteins
blood:air partition coefficient
physiologically based toxicokinetic model
parts per million
skin:air partition coefficient
skin:blood partition coefficient
tissue:blood partition coefficient
cardiac output
liver blood flow
alveolar ventilation
tissue blood flow rate
rate ofamount metabolized
exposed skin surface area
length ofexposure
toluene
bloodvolume
livervolume
Maximal velocity for metabolism
tissue volume
m-xylene
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a
Amet
Ao
Ask
Ca
Cair
Csk
Ct
Cv
Cv,
Cvii
Cvt
DCM
Do
E
EBZ
Et
GFR
Kb
Kix
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